• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, March 1, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New drug target for Ebola, Marburg viruses

Bioengineer by Bioengineer
February 8, 2021
in Health
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

UIC research published in PLOS Pathogens

IMAGE

Credit: Jenny Fontaine/UIC

Ebola and Marburg are among the most deadly viruses, with mortality rates from these infections ranging from 25% to 90%. While no drugs currently are available on the market to prevent infection from these viruses — they belong to a category of viruses called filoviruses, which are known to cause hemorrhagic fever — researchers have identified a few small drug molecules that can block filoviruses from infecting cells by occupying a single site on a glycoprotein in the virus.

Now, researchers at the University of Illinois Chicago have identified a second site on the filovirus glycoprotein to which small drug molecules can bind and prevent infection. The researchers say that small drug molecules that block both glycoprotein sites may be more effective and reduce the risk of side effects.

These findings are reported in the journal PLOS Pathogens.

“We need to identify how these filoviruses get into cells as a means to help us identify or develop drugs that can prevent infection,” said Lijun Rong, UIC professor of microbiology and immunology at the College of Medicine and a corresponding author of the paper. “Even though at the moment Ebola and Marburg are not in the news that often, having drugs in our arsenal in case of a flare-up is invaluable. These viruses also mutate constantly, so having a better understanding of how they work will let us develop next-generation viral inhibitors.”

Rong’s group and his collaborators, led by Rui Xiong, UIC research assistant professor of pharmaceutical sciences at the College of Pharmacy, identified the second glycoprotein binding site by pairing the virus with hundreds of different small drug molecules thought to possibly have an effect on viral entry into cells. Several of the drugs were able to prevent viral entry.

Through a series of experiments using molecular, biophysical and structural experimental techniques, they were able to look more closely at how these drugs were interacting with the virus. They found that the drugs were binding to a previously unknown site on the viral surface glycoprotein required for cell infection.

“The good news is that there are already drugs approved by the FDA that can bind to the new site we identified,” Rong said. “If we can give drugs that bind to the site we newly identified and the site previously identified, it can help prevent viral infection with lower doses of each drug. Interfering with both sites on the viral surface glycoprotein, it also reduces the chances of the glycoprotein mutating to the point that it escapes the effect of the drug combination and is able to infect cells once again.”

###

Xiong is also a corresponding author of the paper. Adam Schafer, Laura Cooper, Raghad Nowar, Hyun Lee, Yangfeng Li, Benjamin Ramirez, Michael Caffrey, Han Cheng of UIC; Norton Peet of Chicago BioSolutions, Inc.; Erica Ollmann Saphire of the LaJolla Institute of Immunology, and Gregory Thatcher, formerly of UIC and now of the University of Arizona, are co-authors on the paper.

This research was partially supported by grant awards from the National Institutes of Health (R41AI12697, R42AI126971).

Media Contact
Jackie Carey
[email protected]

Original Source

https://today.uic.edu/new-drug-target-for-ebola-marburg-viruses

Related Journal Article

http://dx.doi.org/10.1371/journal.ppat.1009312

Tags: Infectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

Single cell sequencing opens new avenues for eradicating leukemia at its source

March 1, 2021
IMAGE

UTA researcher explores effects of trauma at the cellular, tissue levels of the brain

February 26, 2021

Picture books can boost physical activity for youth with autism

February 26, 2021

Oahu marine protected areas offer limited protection of coral reef herbivorous fishes

February 26, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    649 shares
    Share 260 Tweet 162
  • People living with HIV face premature heart disease and barriers to care

    82 shares
    Share 33 Tweet 21
  • Global analysis suggests COVID-19 is seasonal

    38 shares
    Share 15 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    35 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

MaterialsPublic HealthInfectious/Emerging DiseasesGeneticsCell BiologyEcology/EnvironmentTechnology/Engineering/Computer ScienceClimate ChangeBiologyChemistry/Physics/Materials SciencesMedicine/Healthcancer

Recent Posts

  • Virtually unlimited solar cell experiments
  • Root cause: Plant root tips are constrained to a dome shape common to arch bridges
  • Bottling the world’s coldest plasma
  • Wrasses dazzle: how fairy wrasses got their flamboyant colours
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In